Aβ fibrils, APP CTF (WO2)
ANTIBODY monoclonal WO2 laboratory WO2<br />(<a href="http://www.biomedexperts.com/Profile.bme/1057193/Brian_O_Nuallain" target="_new">Brian O'Nuallain</a>,<br />Graduate School of Medicine, University of Tennessee
331171 RESULTS
ANTIBODY monoclonal WO2 laboratory WO2<br />(<a href="http://www.biomedexperts.com/Profile.bme/1057193/Brian_O_Nuallain" target="_new">Brian O'Nuallain</a>,<br />Graduate School of Medicine, University of Tennessee
Portage, United States
ANTIBODY monoclonal WO1 laboratory raised against sonicated amyloid fibrils grown from synthesized Aβ1–40 peptides (epitope within aa 1-16) detects amyloid-beta fibrils; exhibits binding to fibrils in the presence of a large excess of Aβ(1–40) monomer, suggesting
PAPER Matsumoto S, Goto S, Kusaka H, Imai T, Murakami N, Hashizume Y, Okazaki H, Hirano A
PAPER Munoz DG
PAPER Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, Brown RH, Shapiro BE, Lomen-Hoerth C
PAPER Gouveia LO, de Carvalho M
RESEARCH NEWS 2010-08-08 Research News Amyotrophic lateral sclerosis is tragic when it hits in late or middle age, but a rare juvenile form of the disease is all the more devastating because it attacks people in their late teens and early twenties. “Juvenile ALS is a relatively o
RESEARCH NEWS 2010-08-08 Research News Antibodies to synthetic Aβ oligomers, or “globulomers,” improve cognition in a mouse model of Alzheimer disease, according to a paper in yesterday’s Journal of Neuroscience. Scientists led by Heinz Hillen and Ulrich Ebert at Abbot, Ludwigsha
PAPER Brunette KE, Tran PV, Wobken JD, Carlson ES, Georgieff MK
PAPER He Q, Song N, Xu H, Wang R, Xie J, Jiang H
PAPER Tselis A, Khan OA, Lisak RP
PAPER Machado I, González P, Schiöth HB, Lasaga M, Scimonelli TN
PAPER Wang T, Fu FH, Han B, Zhang LM, Zhang XM
PAPER Maximova OA, Murphy BR, Pletnev AG
No filters selected